Circadian rhythm of melatonin in postmenopausal asthmatic women with hormone replacement therapy

Neuroendocrinology Letters

Volumn 23, Issue 3, 2002, Pages 243-248

  Kos Kudla, Beata ^a   Ostrowska, Zofia ^a   Marek, Bogdan ^a   Kajdaniuk, Dariusz ^a   Ciesielska Kopacz, Nelly ^a   Kudla, Marek ^a   Mazur, Bogdan ^a   Glogowska Szelag, Joanna ^a   Nasiek, Maja ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Asthma bronchiale; Circadian rhythm; Hormone replacement therapy; Melatonin

Indexed keywords

ANTIDEPRESSANT AGENT; BUDESONIDE; ESTRADIOL; ESTRODERM TTS FIRM; GLUCOCORTICOID; MEDROXYPROGESTERONE ACETATE; MELATONIN; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; ASTHMA; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS; ESTROGEN THERAPY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION;

AGED; ASTHMA; CIRCADIAN RHYTHM; ESTROGEN REPLACEMENT THERAPY; FEMALE; GLUCOCORTICOIDS; HUMANS; MELATONIN; MIDDLE AGED; POSTMENOPAUSE;

EID: 0035989474     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Suppression of oxygen toxicity by melatonin
2. Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: Role of hormone replacement therapy
3. Plasma melatonin concentration before and during testosterone replacement in Klinefelter's Syndrome: Relation to hepatic indolamine metabolism and sympathoadrenal activity
4. Melatonin attenuates estradiol-induced oxidative damage to DNA: Relevance for cancer prevention
5. Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement
6. Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy
7. Guidelines for the diagnosis and management of asthma
8. Circadian system phase as aspect of temporal morphology: Procedure and illustrative examples
9. Diurnal rhythm of serum melatonin, ACTH and cortisol secretion in asthma patients with long-term glucocorticoid treatment
10. Nocturnal urinary melatonin excretion and plasma cortisol levels in children and adolescents after a single oral dose of dexamethasone
11. Decreased melatonin concentration in Cushing's syndrome
12. Influence of dexamethasone on nocturnal melatonin production in healthy adult subjects
13. Melatonin enhances cortisol levels in aged women: Reversible by estrogens
14. Melatonin enhances cortisol levels in aged but not young women
15. Chronic melatonin treatment and the hypothalamo-pituitary-adrenal axis in the rat: Attenuation of the secretory response to stress and effects on hypothalamic neuropeptide content and release
16. Hormone replacement therapy in postmenopausal asthmatic women
17. Effects of hormone replacement therapy on endocrine and spirometric parameters in asthmatic postmenopausal women
18. Changes in nocturnal melatonin secretion in perimenopausal women: Correlation with endogenous estrogen concentrations
19. Enhanced nocturnal melatonin secretion in women with functional secondary amenorrhea: Relationship to opioid system and endogenous estrogen levels
20. Amplification of nocturnal melatonin secretion in women with functional secondary amenorrhea: Relation to endogenous oestrogen concentration
21. Sex steroids do not alter secretion in the human
22. The effect of estradiol on the production of melatonin in postmenopausal women
23. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women
24. Relationship between the pineal gland and experimentally induced malignant tumors
25. Assessment on the relationship between circadian variations of salivary melatonin levels and type I collagen metabolism in postmenopausal obese women
26. Diurnal profile of melatonin concentrations in patients with major depression: Relationship to the clinical manifestation and antidepressant treatment
27. Melatonin suppresses autoxidation and hydrogen peroxide-induced lipid peroxidation in monkey brain homogenate
28. Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease